Covid-19 jabs to reach 16m Kenyans by 2023, @MOH_Kenya Vax strategy shows:
THREAD OF the phased vaccination breakdown
#PhaseI
1.25 million Frontline health workers & individuals involved in service deliveries in health facilities.
People working in essential services like teachers and staff in educational institutions, police, military, prisons, and immigration officers as well as instructors in religious institutions will be vaccinated. This is expected to be done between Q3 & Q4 of the 2020/2021 FY.
#PhaseII
9.76 million people above 50 years and those who are above 18 years but have one or more medical conditions (comorbidity) e.g cancer, diabetes, sickle cell disease, chronic lung, and cardiovascular diseases among others will be vaccinated. @ncdalliance@kenconetwork
Individuals working in the hospitality and tourism industry will also be factored in this category.
They will be factored in the inoculation exercise which will be done in the 2021/2022 financial year.
#PhaseIII 4.9 million people working in the entertainment, restaurant, retail, and banking sectors will get their shots in this last phase expected to run during the 2022/2023 financial year.
In addition, Kenyans above the age of 18 living in congregate settings like care homes, prisons and detention centres, shelters, street families and densely populated settlements will also receive the vaccine.
The @MOH_Kenya phases however might overlap as more vaccines become available during phases 2 and 3.
@WHO on Wednesday released guidance on who should be given #AstraZeneca's vax & how it will be administered.
See below: 1. It's to be given 3-4 months between 1st & 2nd dose
2. ANYONE above 18years (pretty standard age for adults).
ALSO to be given to older people above 65yrs since there isn't data that shows that new variants will affect the efficacy of #AZ in this age group.
3. Like #Pfizer's, it will not be given to pregnant & breastfeeding women unless they are at risk of contracting #Covid-19.
"We do not have enough information to recommend the vaccine in this group but don't see no reason for it not to be used if the woman is at risk," @WHO's SAGE chair Dr Alejandro craivoto said.
#SouthAfrica on Sunday suspended the use of the #OxfordAstraZeneca vaccine after a small clinical trial suggested that the drug is not effective in preventing mild to moderate illness from the variant dominant in the country.
I spoke to @mosmasika to understand if the new data posed any risk for Kenya which is heavily relying on the #OxfordAstraZeneca vaccine.
He told me: "We should not stop our plans for vaccination just because South Africa has paused #AZ.
We should appreciate that the two countries are experiencing a somewhat different trajectory in terms of numbers and most likely circulating variants."